￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Does taking selegiline/midopir make you excited?

2026-02-01 22:25:32

Check Details
Is the therapeutic effect of Etrasimod-Velsipity good?

2026-02-01 22:25:32

Check Details
What are the usage methods and precautions of Vemurafenib/Zorbovo Tablets?

2026-02-01 22:25:32

Check Details
What is the specific efficacy and effect of Trabectedin?

2026-02-01 22:25:32

Check Details
Do patients need to take Resmetirom for life?

2026-02-01 22:25:32

Check Details
Can Revumenib-Revuforj cure melanoma?

2026-02-01 22:25:32

Check Details
How effective is selegiline/midopir in the treatment of Parkinson's disease?

2026-02-01 22:25:32

Check Details
What is the mechanism of action of Etrasimod-Velsipity?

2026-02-01 22:25:32

Check Details
Can vemurafenib/zobovo be classified as a targeted therapy?

2026-02-01 22:25:32

Check Details
Do I need to continue taking Trabectedin, and for how long?

2026-02-01 22:25:32

Check Details
Is Resmetirom currently on the market in China?

2026-02-01 22:25:32

Check Details
FDA approves CytoCell CDx for Revumenib-Revuforj treatment of KMT2A mutated acute leukemia

2026-02-01 22:25:32

Check Details
Category
相关知识